Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2701 NW Vaughn St
Ste 350
Portland, OR 97210Phone+1 503-279-8252
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Family Medicine, 1972 - 1975
- Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 1969 - 1972
- Providence St. Vincent Medical CenterInternship, Transitional Year, 1965 - 1966
- Perelman School of Medicine at the University of PennsylvaniaClass of 1965
Certifications & Licensure
- NV State Medical License 1970 - Present
- OR State Medical License 1970 - 2023
- WA State Medical License 2014 - 2017
Clinical Trials
- Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Start of enrollment: 2008 Sep 01
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
- Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsGepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group StudyRobert J. Bielski, Lynn Cunningham, Joseph P. Horrigan, Peter D. Londborg, Ward T. Smith
The Journal of Clinical Psychiatry. 2008-03-18 - 31 citationsA randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.Richard C. Shelton, Kirsten L. Haman, Mark Hyman Rapaport, Ari Kiev, Ward T. Smith
The Journal of Clinical Psychiatry. 2006-11-15 - 70 citationsEfficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.Michael R. Liebowitz, Nicholas DeMartinis, Karen L. Weihs, Peter D. Londborg, Ward T. Smith
The Journal of Clinical Psychiatry. 2003-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: